Affiliation:
1. Laboratory of Methods, Department of Biophysics, Institute of Biosciences, Federal University of Rio Grande do Sul, 91.501–970, Porto Alegre, RS, Brazil
Abstract
The discovery of biomarkers that confer high confidence of presymptomatic Alzheimer's disease (AD) diagnosis would be a valuable tool to study the etiology of the disease, to find risk factors, to discover more treatments and medicines. The present work reviews the potential biomarkers of AD based on the concentration changes of small molecules and chemical elements in noninvasive samples (urine, saliva, hair and others). An updated table with 74 target compounds is produced and ranked. Until the present date, there are a few biomarkers, present in urine, with the most promising potential: isoprostane 8,12-iso-iPF2a-VI, total free amino acids, 8-hydroxy-2′-deoxyguanosine, glycine and enzymatic activity of NaCl-stimulated PON1. All show increased levels in AD carriers, with the exception of NaCl-stimulated PON1.
Subject
Biochemistry (medical),Clinical Biochemistry,Drug Discovery
Reference50 articles.
1. Duthey B. Background Paper 6.11: Alzheimer Disease and Other Dementias. A Public Health Approach to Innovation, Update on 2004 Background Paper. WHO, Geneva, Switzerland, 1–74 (2013).
2. Interactions of pathological proteins in neurodegenerative diseases
3. Unresolved questions in Alzheimer’s research: will biomarkers help?
4. The clinical use of structural MRI in Alzheimer disease
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献